|
High $0.00 |
Low $0.00 |
Trades 3 |
Turnover $1,511 |
Volume 672,333 |
| 30 June 2023 at 1:49pm | ||||
|
Market Cap (3-Jul) $5,671,263 (1,275th) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 672,333 |
Shortsold (23-Mar) 355,000 (0.00%) (603rd) |
|
52w High $0.077 |
52w Low $0.036 |
P/E - |
EPS 0 |
GTG released this announcement to the ASX on 30 August 2022, 13:07. The announcement is marked as price sensitive, and is 88 page(s) in length and 2.75MB in size.
You can view all announcements from GTG and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from GTG | |
|---|---|
| Notification of cessation of securities - GTG | 10 May 2023, 13:54 |
| Updated Investor Presentation and Investor Webinar | 2 May 2023, 8:59 |
| Publication Validates geneType for Melanoma Risk Assessment | 28 April 2023, 9:02 |
| Annual Report to Shareholders and Appendix 4E | 30 August 2022, 13:07 |
| GeneType Business Update Presentation | 1 August 2022, 8:17 |
| Q4 FY22 Results Milestones and Growth | 28 July 2022, 8:30 |
| GeneType Risk Test Implemented in 9 Siles Health Clinics | 18 July 2022, 9:25 |
You must be logged in to post a reply.
Genetic Technologies 